Change of the blood concentration of tacrolimus after the switch from fluconazole to voriconazole in patients receiving allogeneic hematopoietic stem cell transplantation

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 12, 2006, Pages 2528-2531

  Kawazoe, Hitoshi ^a,c   Takiguchi, Yoshiharu ^c   Tanaka, Hiroaki ^a   Fukuoka, Noriyasu ^a   Ohnishi, Hiroaki ^b   Ishida, Toshihiko ^b   Houchi, Hitoshi ^a  

^a KAGAWA UNIVERSITY HOSPITAL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Concentration; Interaction; Tacrolimus; Transplantation; Voriconazole

Indexed keywords

BILIRUBIN; CYTOCHROME P450 3A4; FLUCONAZOLE; FOSFLUCONAZOLE; TSUKUBAENOLIDE; VORICONAZOLE;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER FUNCTION; MYCOSIS;

FLUCONAZOLE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PYRIMIDINES; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TACROLIMUS; TRIAZOLES;

EID: 33845351776     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2528     Document Type: Article

References (21)

1. Dykewicz C. A., Clin. Infect. Dis., 33, 139-144 (2001).
2. Kami M., Imataki O., Taniguchi S., Kanemaru M., Hayashi T., Jpn. J. Med. Mycol., 45, 189-202 (2004).
3. Leather H., Boyette R. M., Tian L., Wingard F. R., Biol. Blood Marrow Transplant., 12, 325-334 (2006).
4. Osowski C. L., Dix S. P., Lin L. S., Mullins R. E., Geller R. B., Wingard J. R., Transplantation, 61, 1268-1272 (1996).
5. Gilbert D. N., Moellering R. C., Eliopoulos G. M., Sande M. A., "The Sanford Guide to Antimicrobial Therapy 2005 (Japanese edition)," 35th ed., ed. by Totsuka K., Hashimoto H., Life Science Publishing, Tokyo, 2005, p. 261.
6. JSHCT monograph Vol. 3: 〈http://www.jshct.com/〉, The Japan Society for Hematopoietic Cell Transplantation Web, 22 May, 2006.
7. Fortun J., Martin-Davila P., Sanchez M. A., Pintado V., Alvarez M. E., Sanchez-Sousa A., Moreno S., Eur. J. Clin. Microbiol. Infect. Dis., 22, 408-413 (2003).
8. Jeu L., Piacenti F. J., Lyakhovetskiy A. G., Fung H. B., Clin. Ther., 25, 1321-1381 (2003).
9. Romero A. J., Pogamp P. L., Nilsson L. G., Wood N., Clin. Pharmacol. Ther., 71, 226-234 (2002).
10. Niwa T., Shiraga T., Takagi A., Yakugaku Zasshi, 125, 795-805 (2005).
11. Mahnke C. B., Sutton R. M., Venkataramanan R., Michaels M., Kurland G., Boyle G. J., Law Y. M., Miller S. A., Pigula F. A., Gandhi S., Webber S. A., Pediatr. Transplant., 7, 474-478 (2003).
12. Venkataramanan R., Zang S., Gayowski T., Singh N., Antimicrob. Agents Chemother., 46, 3091-3093 (2002).
13. Pai M. P., Allen S., Clin. Infect. Dis., 36, 1089-1091 (2003).
14. Caudron E., Jullien V., Amrein C., Guillemain R., Chevallier P., Beller C. L., Louet A. L., Billaud E. M., Fundam. Clin. Pharmacol., 17, 183 (2003) (Abstracts of papers).
15. Cool R. M., Ippoliti C., Cuellar S., Donato M. L., Biol. Blood Marrow Transplant., 10, 293 (2004) (Abstracts of papers).
16. Tintillier M., Kirch L., Goffin E., Cuvelier C., Pochet J. M., Nephrol. Dial. Transplant., 20, 664-665 (2005).
17. Kojima R., Kami M., Kanda Y., Kusumi E., Kishi Y., Tanaka Y., Yoshioka S., Morishima S., Fujisawa S., Mori S., Kasai M., Hatanaka K., Tajima K., Kasai M., Mitani K., Ichinohe T., Hirai H., Taniguchi S., Sakamaki H., Harada M., Takaue Y., Bone Marrow Transplant., 36, 667-674 (2005).
18. Laughlin M. J., Eapen M., Rubinstein P., Wagner J. E., Zhang M. J., Champlin R. E., Stevens C., Barker J. N., Gale R. P., Lazarus H. M., Marks D. I., Rood J. J., Scaradavou A., Horowitz M. M., N. Engl. J. Med., 351, 2265-2275 (2004).
19. Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., Bosi A., Jacobsen N., Ruutu T., Lima M. D., Finke J., Frassoni F., Gluckman E., N. Engl. J. Med., 351, 2276-2285 (2004).
20. Shimoeda S., Ohta S., Kobayashi H., Saitou H., Kubota A., Yamato S., Shimada K., Sasaki M., Kawano K., Biol. Pharm. Bull., 28, 477-480 (2005).
21. Vfend-package insert: 〈http://www.fda.gov/cder/foi/label/2003/ 21267slr003,21266slr002_vfend_lbl.pdf〉, U. S. Food and Drug Administration Web, 3 June, 2006.